These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships. Arakawa K; Inamasu M; Matsumoto M; Okumura K; Yasuda K; Akatsuka H; Kawanami S; Watanabe A; Homma K; Saiga Y; Ozeki M; Iijima I Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1984-93. PubMed ID: 9433768 [TBL] [Abstract][Full Text] [Related]
8. Studies on antidiabetic agents. X. Synthesis and biological activities of pioglitazone and related compounds. Momose Y; Meguro K; Ikeda H; Hatanaka C; Oi S; Sohda T Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1440-5. PubMed ID: 1934164 [TBL] [Abstract][Full Text] [Related]
9. A potential solution for the shortage of donors in islet transplantation using a novel oral antidiabetic agent, troglitazone. Nagai T; Yasunami Y; Nagata N; Ryu S; Ono J; Ikeda S Transplant Proc; 1995 Dec; 27(6):3405. PubMed ID: 8540020 [No Abstract] [Full Text] [Related]
10. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus. Johnson MD; Campbell LK; Campbell RK Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic stereoselectivity of troglitazone, an antidiabetic agent, in the KK mouse. Izumi T; Enomoto S; Hoshiyama K; Sasahara K; Sugiyama Y Biopharm Drug Dispos; 1997 May; 18(4):305-24. PubMed ID: 9158879 [TBL] [Abstract][Full Text] [Related]
12. Troglitazone (CS-045): a new antidiabetic agent. Kaneko T Horm Metab Res; 1997 May; 29(5):203-13. PubMed ID: 9228204 [No Abstract] [Full Text] [Related]
13. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones. Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of troglitazone. Loi CM; Young M; Randinitis E; Vassos A; Koup JR Clin Pharmacokinet; 1999 Aug; 37(2):91-104. PubMed ID: 10496299 [TBL] [Abstract][Full Text] [Related]
15. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice. Fujiwara T; Okuno A; Yoshioka S; Horikoshi H Metabolism; 1995 Apr; 44(4):486-90. PubMed ID: 7723671 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of troglitazone, an antidiabetic agent: prediction of in vivo stereoselective sulfation and glucuronidation from in vitro data. Izumi T; Hosiyama K; Enomoto S; Sasahara K; Sugiyama Y J Pharmacol Exp Ther; 1997 Mar; 280(3):1392-400. PubMed ID: 9067328 [TBL] [Abstract][Full Text] [Related]
17. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative. Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726 [TBL] [Abstract][Full Text] [Related]
19. A short synthesis of troglitazone: an antidiabetic drug for treating insulin resistance. Cossy J; Menciu C; Rakotoarisoa H; Kahn PH; Desmurs JR Bioorg Med Chem Lett; 1999 Dec; 9(24):3439-40. PubMed ID: 10617087 [TBL] [Abstract][Full Text] [Related]
20. Prediction of the human pharmacokinetics of troglitazone, a new and extensively metabolized antidiabetic agent, after oral administration, with an animal scale-up approach. Izumi T; Enomoto S; Hosiyama K; Sasahara K; Shibukawa A; Nakagawa T; Sugiyama Y J Pharmacol Exp Ther; 1996 Jun; 277(3):1630-41. PubMed ID: 8667232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]